Mayumi Squalene, Deep Sea Shark Liver Oil Extract 120 Capsules, high quality and best price

Squalene is an intermediate in the cholesterol biosynthesis pathway. It was so named because of its occurrence in shark liver oil, which contains large quantities and is considered its richest source. However, it is widely distributed in nature, ands found in olive oil, palm oil, wheat-germ oil, amaranth oil, and rice bran oil. Squalene, the main component of skin surface polyunsaturated lipids, shows some advantages for the skin as an emollient and antioxidant, and for hydration and its antitumor activities. It is also used as a material in topically applied vehicles such as lipid emulsions.

Purchase Mayumi Squalene, Deep Sea Shark Liver Oil Extract Product of Japan

Buy Mayumi Squalene pills and supplement on sale today

This Squalene is 99.9% pure and extracted from liver oil of Aizame sharks, who inhabit non-polluted waters at depths of 3,000 feet. This superior natural oil is a product of Japan. Great care is taken in it's preparation to insure potency and stability.

Suggested Use: As a nutritional supplement for adults, take one to three Mayumi Squalene, Deep Sea Shark Liver Oil Extract capsules daily with meals.

Mayumi Squalene, Deep Sea Shark Liver Oil Extract Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
Squalene 450 mg

No vitamins A, D artificial colors or flavors.

Mayumi Squalene, Deep Sea Shark Liver Oil Extract

Mangosteen home

Buy Mayumi Squalene supplement, deep sea shark liver oil extract

Can fish oils be taken together with this product?
    Probably, we don't see why they can't be taken the same day.

Vaccination, squalene and anti-squalene antibodies: facts or fiction?
Eur J Intern Med. 2010; Lippi G, Targher G. Diagnostica Ematochimica, Dipartimento di Patologia e Medicina di Laboratorio, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
Squalene, a hydrocarbon obtained for commercial purposes primarily from shark liver oil and other botanic sources, is increasingly used as an immunologic adjuvant in several vaccines, including seasonal and the novel influenza A (H1N1) 2009 pandemic flu vaccines. Nearly a decade ago, squalene was supposed to be the experimental anthrax vaccine ingredient that caused the onset of Persian Gulf War syndrome in many veterans, since antibodies to squalene were detected in the blood of most patients affected by this syndrome. This evidence has raised a widespread concern about the safety of squalene containing adjuvants (especially MF59) of influenza vaccines. Nevertheless, further clinical evidence clearly suggested that squalene is poorly immunogenic, that low titres of antibodies to squalene can be also detected in sera from healthy individuals, and that neither the presence of anti-squalene antibodies nor their titre is significantly increased by immunization with vaccines containing squalene (or MF59) as an adjuvant. This review summarizes the current scientific evidence about the relationship between squalene, anti-squalene antibodies and vaccination.